StockData
Illumina, Inc. logo

Illumina, Inc. (ILMN) stock

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3013% above fair value
$202.61+4.61 (+2.33%)

Close on Nov 17, 2026Market cap $30.63BP/E 34.8Yield –

Illumina price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Illumina's price to sales ratio was 7.2× on Nov 11, 2026, against 4.8× a year earlier. Over the last 5 years it ranged from 2.8× to 13.1×, with a median of 5.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.2×+2.4
2025Dec 31, 20254.8×−0.0
2024Dec 31, 20244.8×+0.0
2023Dec 29, 20234.8×−1.8
2022Dec 30, 20226.7×−6.4
2021Dec 31, 202113.1×−3.7
2020Dec 31, 202016.8×+2.6
2019Dec 31, 201914.2×+0.6
2018Dec 31, 201813.6×+1.3
2017Dec 29, 201712.3×+4.4
2016Dec 30, 20167.9×−5.3
2015Dec 31, 201513.2×−2.3
2014Dec 31, 201415.5×+3.7
2013Dec 31, 201311.8×+5.4
2012Dec 31, 20126.4×+2.6
2011Dec 30, 20113.8×−6.5
2010Dec 31, 201010.3×+3.8
2009Dec 31, 20096.6×–

More Illumina figures

See a number that looks wrong?